Comments
Loading...

INmune Bio

INMBNASDAQ
Logo brought to you by Benzinga Data
$5.44
00.00%
Pre-Market: 4:00 PM EDT

INmune Bio (NASDAQ:INMB) Stock, Earnings Estimates, EPS, And Revenue

INmune Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Oct 31
EPS
$-0.600
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
$42K

Analyze the earnings history of INmune Bio using advanced sorting and filters.

Data brought to you by Benzinga APIs

INmune Bio (INMB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-10-31$-0.60$-0.50-20.0 %
Jun 20242024-08-01$-0.50$-0.6320.6 %
Mar 20242024-05-09$-0.61$-0.53-15.1 %
Dec 20232024-03-28$-0.47$-0.44-6.82 %

INmune Bio (INMB) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Mar 20242024-05-09$14.00K$30.00K-53.3 %
Dec 20232024-03-28$28.00K$40.00K-30.0 %
Sep 20212021-11-03$14.00K$970.00K-98.6 %

FAQ

Q

When is INmune Bio (NASDAQ:INMB) reporting earnings?

A

INmune Bio ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 31, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for INmune Bio (NASDAQ:INMB)?

A

INmune Bio ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 31, 2024 for Q3 and the Actual EPS was $-0.60, which missed the estimate of $-0.50.

Q

What were INmune Bio’s (NASDAQ:INMB) revenues?

A

INmune Bio ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 31, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch